Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping Meeting Abstract

  


Authors: Paik, P.; Drilon, A.; Yu, H.; Rekhtman, N.; Borsu, L.; Ginsberg, M.; Berger, M.; Ladanyi, M.; Rudin, C. M.
Abstract Title: Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
Meeting Title: 16th World Conference on Lung Cancer (WCLC)
Journal Title: Journal of Thoracic Oncology
Volume: 10
Issue: 9 Suppl. 2
Meeting Dates: 2015 Sep 6-9
Meeting Location: Denver, CO
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S178
End Page: S179
Language: English
ACCESSION: WOS:000370365100225
PROVIDER: wos
PUBMED: 26710300
DOI: 10.1016/S1556-0864(16)30010-7
Notes: Meeting Abstract: ORAL03.07 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    424 Rekhtman
  2. Michelle S Ginsberg
    235 Ginsberg
  3. Helena Alexandra Yu
    281 Yu
  4. Marc Ladanyi
    1326 Ladanyi
  5. Paul K Paik
    255 Paik
  6. Laetitia A Borsu Valente
    81 Borsu Valente
  7. Michael Forman Berger
    765 Berger
  8. Alexander Edward Drilon
    632 Drilon
  9. Charles Rudin
    488 Rudin
Related MSK Work